| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
KaroBio AB (K.F.K.), Novum, SE-141 57 Huddinge, Sweden; and Department of BioSciences and Medical Nutrition (L.A.H., L.-A.H., M.W., J.-Å.G.), Karolinska Institutet, Novum, SE-141 57 Huddinge, Sweden
Correspondence: Address all correspondence and requests for reprints to: Jan-Åke Gustafsson, Department of BioSciences and Medical Nutrition, Karolinska Institutet, Novum, SE-141 57 Huddinge, Sweden. E-mail: jan-ake.gustafsson{at}mednut.ki.se
We have known for many years that estrogen is more than the female hormone. It is essential in the male gonads, and in both sexes, estrogen has functions in the skeleton and central nervous system, on behavior, and in the cardiovascular and immune systems. An important aspect of the discovery of estrogen receptor (ER) ß is that the diverse functions of estrogen can now be divided into those mediated by ER
and those mediated by ERß. Pharmacological exploitation of this division of the labors of estrogen is facilitated by the ligand-binding specificity and selective tissue distribution of the two ERs. Because the ligand binding domains of ER and ERß are significantly different from each other, selective ligands can be (and have been) developed to target the estrogenic pathway that is malfunctioning, without interfering with the other estrogen-regulated pathways. Because of the absence of ERß from the adult pituitary and endometrium, ERß agonists can be used to target ERß with no risk of adverse effects from chemical castration and uterine cancer. Some of the diseases in which there is hope that ERß agonists will be of benefit are prostate cancer, autoimmune diseases, colon cancer, malignancies of the immune system, and neurodegeneration.
This article has been cited by other articles:
 |
|
 |
|
  T. L. McCarthy, M. E. Clough, C. M. Gundberg, and M. Centrella Expression of an estrogen receptor agonist in differentiating osteoblast cultures PNAS, May 13, 2008; 105(19): 7022 - 7027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Antal, A. Krust, P. Chambon, and M. Mark Sterility and absence of histopathological defects in nonreproductive organs of a mouse ER{beta}-null mutant PNAS, February 19, 2008; 105(7): 2433 - 2438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee What Can We Learn from Rodents about Prolactin in Humans? Endocr. Rev., February 1, 2008; 29(1): 1 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Nettles, G. Gil, J. Nowak, R. Metivier, V. B. Sharma, and G. L. Greene CBP Is a Dosage-Dependent Regulator of Nuclear Factor-{kappa}B Suppression by the Estrogen Receptor Mol. Endocrinol., February 1, 2008; 22(2): 263 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. McCARTHY Estradiol and the Developing Brain Physiol Rev, January 1, 2008; 88(1): 91 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Wang, L. Liu, and R. D. Brinton Estradiol-17 -Induced Human Neural Progenitor Cell Proliferation Is Mediated by an Estrogen Receptor -Phosphorylated Extracellularly Regulated Kinase Pathway Endocrinology, January 1, 2008; 149(1): 208 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cvoro, D. Tatomer, M.-K. Tee, T. Zogovic, H. A. Harris, and D. C. Leitman Selective Estrogen Receptor- Agonists Repress Transcription of Proinflammatory Genes J. Immunol., January 1, 2008; 180(1): 630 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kawagoe, M. Ohmichi, S. Tsutsumi, T. Ohta, K. Takahashi, and H. Kurachi Mechanism of the Divergent Effects of Estrogen on the Cell Proliferation of Human Umbilical Endothelial Versus Aortic Smooth Muscle Cells Endocrinology, December 1, 2007; 148(12): 6092 - 6099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ray, F. Xu, P. Li, N. S. Sanchez, H. Wang, and S. K. Das Increased Level of Cellular Bip Critically Determines Estrogenic Potency for a Xenoestrogen Kepone in the Mouse Uterus Endocrinology, October 1, 2007; 148(10): 4774 - 4785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Alevizaki, K Saltiki, A Cimponeriu, I Kanakakis, N Xita, C C Alevizaki, I Georgiou, and H-L Sarika Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor {alpha} polymorphic variants Eur. J. Endocrinol., April 1, 2007; 156(4): 489 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Galluzzo, F. Caiazza, S. Moreno, and M. Marino Role of ER{beta} palmitoylation in the inhibition of human colon cancer cell proliferation Endocr. Relat. Cancer, March 1, 2007; 14(1): 153 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Baker, R. B. Beckstead, D. J. Mangelsdorf, and C. S. Thummel Functional interactions between the Moses corepressor and DHR78 nuclear receptor regulate growth in Drosophila Genes & Dev., February 15, 2007; 21(4): 450 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Ji, L. Chang, F. Z. Stanczyk, M. Ookhtens, A. Sherrod, and A. Stolz Impaired Dihydrotestosterone Catabolism in Human Prostate Cancer: Critical Role of AKR1C2 as a Pre-Receptor Regulator of Androgen Receptor Signaling Cancer Res., February 1, 2007; 67(3): 1361 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cvoro, S. Paruthiyil, J. O. Jones, C. Tzagarakis-Foster, N. J. Clegg, D. Tatomer, R. T. Medina, M. Tagliaferri, F. Schaufele, T. S. Scanlan, et al. Selective Activation of Estrogen Receptor-{beta} Transcriptional Pathways by an Herbal Extract Endocrinology, February 1, 2007; 148(2): 538 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Harris Estrogen Receptor-{beta}: Recent Lessons from in Vivo Studies Mol. Endocrinol., January 1, 2007; 21(1): 1 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rice and S. A Whitehead Phytoestrogens and breast cancer -promoters or protectors? Endocr. Relat. Cancer, December 1, 2006; 13(4): 995 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Ohnemus, M. Uenalan, J. Inzunza, J.-A. Gustafsson, and R. Paus The Hair Follicle as an Estrogen Target and Source Endocr. Rev., October 1, 2006; 27(6): 677 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. N. Duong, S. Elliott, D. E. Frigo, L. I. Melnik, L. Vanhoy, S. Tomchuck, H. P. Lebeau, O. David, B. S. Beckman, J. Alam, et al. AKT Regulation of Estrogen Receptor {beta} Transcriptional Activity in Breast Cancer. Cancer Res., September 1, 2006; 66(17): 8373 - 8381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Nock, M. S. Cicek, L. Li, X. Liu, B. A. Rybicki, A. Moreira, S. J. Plummer, G. Casey, and J. S. Witte Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk Carcinogenesis, September 1, 2006; 27(9): 1842 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-K. Leung, P. Mak, S. Hassan, and S.-M. Ho Estrogen receptor (ER)-beta isoforms: A key to understanding ER-beta signaling PNAS, August 29, 2006; 103(35): 13162 - 13167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Yaal-Hahoshen, S. Shina, L. Leider-Trejo, I. Barnea, E. L. Shabtai, E. Azenshtein, I. Greenberg, I. Keydar, and A. Ben-Baruch The Chemokine CCL5 as a Potential Prognostic Factor Predicting Disease Progression in Stage II Breast Cancer Patients Clin. Cancer Res., August 1, 2006; 12(15): 4474 - 4480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A Riancho, M. T Zarrabeitia, C. Valero, C. Sanudo, V. Mijares, and J. Gonzalez-Macias A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density. Eur. J. Endocrinol., July 1, 2006; 155(1): 53 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Christian, P. Y. Liu, S. Harrington, M. Ruan, V. M. Miller, and L. A. Fitzpatrick Intimal Estrogen Receptor (ER){beta}, But Not ER{alpha} Expression, Is Correlated with Coronary Calcification and Atherosclerosis in Pre- and Postmenopausal Women J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2713 - 2720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Marino, P Galluzzo, S Leone, F Acconcia, and P Ascenzi Nitric oxide impairs the 17{beta}-estradiol-induced apoptosis in human colon adenocarcinoma cells. Endocr. Relat. Cancer, June 1, 2006; 13(2): 559 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Li, F. Sotgia, M. A. Vuolo, M. Li, W. C. Yang, R. G. Pestell, J. A. Sparano, and M. P. Lisanti Caveolin-1 Mutations in Human Breast Cancer: Functional Association with Estrogen Receptor {alpha}-Positive Status Am. J. Pathol., June 1, 2006; 168(6): 1998 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J E Sanchez-Criado, J M. de las Mulas, C Bellido, V M Navarro, R Aguilar, J C Garrido-Gracia, M M Malagon, M Tena-Sempere, and A Blanco Gonadotropin-secreting cells in ovariectomized rats treated with different oestrogen receptor ligands: a modulatory role for ER{beta} in the gonadotrope? J. Endocrinol., February 1, 2006; 188(2): 167 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sun, W. J. Langer, K. Devish, and P. H. Lane Compensatory kidney growth in estrogen receptor-{alpha} null mice Am J Physiol Renal Physiol, February 1, 2006; 290(2): F319 - F323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Arnold and M. R. Blackman Does DHEA Exert Direct Effects on Androgen and Estrogen Receptors, and Does It Promote or Prevent Prostate Cancer? Endocrinology, November 1, 2005; 146(11): 4565 - 4567. [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Harris, E. Besselink, S. M. Henning, V. L. W. Go, and D. Heber Phytoestrogens Induce Differential Estrogen Receptor Alpha- or Beta-Mediated Responses in Transfected Breast Cancer Cells Experimental Biology and Medicine, September 1, 2005; 230(8): 558 - 568. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
